Company / Cash per Share
NextCure, Inc. Cash per Share History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.79
FY2021
5-year range
$0.79 / $24.80
FY2019-FY2021
Trend
-62.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $24.80 to $0.79 over the past 2 years.
Based on SEC 10-K filings.
0.79 in FY2021.
Declined from $24.80 to $0.79 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, cash per share decreased 62.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.79 | -62.4% |
| FY2020 | $2.11 | -91.5% |
| FY2019 | $24.80 | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026